icts: site n-alysis

Site n-AlysisTM

Identify and Qualify Sites

Gregg Sweet, MBA VP Strategy and Development [email protected] o. (919) 388-3966 c. (919) 523-3717 www.icts.us

Who Is ICTS?

Integrated Clinical Trial Services Pre-Trial Preparation

Recruitment/ Enrollment

Retention/ Compliance

Enrollment Success

ICTS is a Clinical Trials Support Company that specializes in achieving superior results in research studies by building and maintaining stronger connections throughout the entire clinical trial process. Our innovative and customized communication models provide the foundation for higher quality data and results.

Pre-Trial Preparation

Recruitment/ Enrollment


Enrollment Success

Site n-Alysis™ Identify / Qualify

Site n-Alysis™ Identify / Qualify Pre-Trial

Preparation Recruitment/ Enrollment


Enrollment Success

Site n-Alysis™ allows you to identify and qualify potential study sites based on surrounding patient population as well as therapeutic specialty, investigator experience, trial volume and more.

Mapping is an important part of the analysis because it can also uncover barriers such as water features that would not be evident in a spreadsheet.




Enrollment Success

What Is Site n-Alysis™? Site n-Alysis is a proprietary process that models patient prevalence to find sites and potential site locations in more than 60 countries that have access to the patients you need for your clinical trial. Sites with access to more subjects can be more successful enrollers. Once prospective sites have been identified based on their access to patients, the Site n-Alysis process then creates site profiles to compare factors such as investigator experience, trial volume, ability to accept new trials, IRB status, and much more. The Site n-Alysis process delivers market and national maps of sites including prevalence and geographic features such as highways, public transportation, rivers, etc., and may include investigator interview summaries.




Enrollment Success

How Does Site n-Alysis Work? Using its proprietary epidemiological process, ICTS creates a national prevalence model for your protocol for each country under consideration. ICTS models the patient populations at local levels and our analysis can be done at the city, county, Zip code or census tract level (or equivalent per country). If there is no existing site list to evaluate, ICTS identifies potential sites in the areas with high patient populations, and screens them according to the requirements of the protocol. To allow our clients to compare sites, ICTS scores sites based on criteria that are most relevant to the study and most predictive of their success. ICTS can deliver a variety of reports, maps, tables and site interview summaries to allow clients to make informed site selections.




Enrollment Success

Prevalence Density This map illustrates the effects of factoring for prevalence density. Because many diseases tend to conform to the general population, evaluating the prevalence on a per capita basis can often help identify markets that are likely to be more efficient for both site selection as well as advertising support.




Enrollment Success

Prequalified Sponsors Study sponsors are able to prequalify sites based on the unique requirements of the study protocol. Sites are then scored with regard to how well they appear to conform to the study requirements, including adjacent patient population (adjusted for inclusion / exclusion criteria), investigator profiles, comparable trial volume, IRB status, and more.




Enrollment Success

Population Datasets Site n-Alysis is supported by thousands of population datasets as well as in-country experts worldwide. Brazil is just one of over 60 countries for which we are able to provide in-depth analysis.




Enrollment Success

Overlapping Catchment This map illustrates the results of comparing three current and/or proposed clinical trial research sites in the San Francisco-Oakland area. The analysis is extended to consider the effects of overlapping catchment areas, i.e. the degree to which multiple sites are competing for the same patients.

For more information contact:

Gregg Sweet, MBA VP Strategy and Development [email protected] o. (919) 388-3966 c. (919) 523-3717 f. (919) 324-3501 www.icts.us

icts: site n-alysis

Health & Medicine